Works matching IS 00302414 AND DT 2022 AND VI 100 AND IP 2
Results: 8
Front & Back Matter.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 1, doi. 10.1159/000522299
- Publication type:
- Article
Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 89, doi. 10.1159/000521141
- By:
- Publication type:
- Article
Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 82, doi. 10.1159/000521033
- By:
- Publication type:
- Article
Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 74, doi. 10.1159/000520938
- By:
- Publication type:
- Article
Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 114, doi. 10.1159/000520833
- By:
- Publication type:
- Article
Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 101, doi. 10.1159/000520582
- By:
- Publication type:
- Article
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 124, doi. 10.1159/000519767
- By:
- Publication type:
- Article
Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292
- By:
- Publication type:
- Article